{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:22:38Z","timestamp":1761744158476,"version":"3.37.3"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1124\/jpet.115.226092","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T02:45:15Z","timestamp":1436409915000},"page":"406-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling"],"prefix":"10.1016","volume":"354","author":[{"given":"Julia","family":"Straubinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Sch\u00f6ttle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadja","family":"Bork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hariharan","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"D\u00fcnnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Russwurm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meinrad","family":"Gawaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Friebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Nemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viacheslav O.","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Lukowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.226092_bib1","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.1013077107","article-title":"Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy","volume":"107","author":"Adamo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.226092_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/cvr\/cvn230","article-title":"Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction","volume":"81","author":"Ainscough","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.115.226092_bib3","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ejheart.2008.09.016","article-title":"Effects of phosphodiesterase-5 inhibition by sildenafil in the pressure overloaded right heart","volume":"10","author":"Andersen","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1124\/jpet.115.226092_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/CIRCULATIONAHA.112.000056","article-title":"Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial","volume":"127","author":"Andersen","year":"2013","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.226092_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1074248413518971","article-title":"Novel approaches and opportunities for cardioprotective signaling through 3\u2032,5\u2032-cyclic guanosine monophosphate manipulation","volume":"19","author":"Bice","year":"2014","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1124\/jpet.115.226092_bib6","doi-asserted-by":"crossref","first-page":"e003731","DOI":"10.1161\/JAHA.112.003731","article-title":"Protein kinase g i\u03b1 inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo","volume":"1","author":"Blanton","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/jpet.115.226092_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/01.HYP.0000156878.17006.02","article-title":"Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system","volume":"45","author":"Booz","year":"2005","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.226092_bib8","doi-asserted-by":"crossref","first-page":"H361","DOI":"10.1152\/ajpheart.00843.2013","article-title":"Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterload","volume":"307","author":"Borgdorff","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.115.226092_bib9","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","article-title":"Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney","volume":"103","author":"Crowley","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.226092_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1124\/jpet.115.226092_bib11","doi-asserted-by":"crossref","first-page":"e0118664","DOI":"10.1371\/journal.pone.0118664","article-title":"The emperor\u2019s new clothes: PDE5 and the heart","volume":"10","author":"Degen","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.115.226092_bib12","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.115.226092_bib13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/eurheartj\/ehr445","article-title":"Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I","volume":"34","author":"Frantz","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.115.226092_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jcp.20197","article-title":"Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation","volume":"202","author":"Fredj","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1124\/jpet.115.226092_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.febslet.2004.08.030","article-title":"Distribution of IRAG and cGKI-isoforms in murine tissues","volume":"575","author":"Geiselh\u00f6ringer","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1124\/jpet.115.226092_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/HYPERTENSIONAHA.110.164327","article-title":"Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1","volume":"57","author":"Giachini","year":"2011","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.226092_bib17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/CIRCRESAHA.114.302437","article-title":"Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes","volume":"114","author":"G\u00f6tz","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/jpet.115.226092_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.HYP.29.1.366","article-title":"Angiotensin II signaling in vascular smooth muscle. New concepts","volume":"29","author":"Griendling","year":"1997","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.226092_bib19","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1073\/pnas.94.12.6391","article-title":"Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block","volume":"94","author":"Hein","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.226092_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology","volume":"112","author":"Higuchi","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1124\/jpet.115.226092_bib21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s001090100246","article-title":"Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy","volume":"79","author":"Hoffmann","year":"2001","journal-title":"J Mol Med (Berl)"},{"key":"10.1124\/jpet.115.226092_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-3-540-68964-5_8","article-title":"cGMP regulated protein kinases (cGK)","volume":"191","author":"Hofmann","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/jpet.115.226092_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCRESAHA.109.207456","article-title":"Intramyocardial fibroblast myocyte communication","volume":"106","author":"Kakkar","year":"2010","journal-title":"Circ Res"},{"key":"10.1124\/jpet.115.226092_bib24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/HYPERTENSIONAHA.111.189423","article-title":"Angiotensin II receptor-induced cardiac remodeling in mice without angiotensin II","volume":"59","author":"Karnik","year":"2012","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.226092_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11897-012-0101-0","article-title":"Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials","volume":"9","author":"Kass","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1124\/jpet.115.226092_bib26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","article-title":"Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments","volume":"165","author":"Keravis","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.115.226092_bib27","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1210\/en.2007-0182","article-title":"Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling","volume":"148","author":"Kili\u0107","year":"2007","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.115.226092_bib28","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/CIRCRESAHA.109.208314","article-title":"Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart","volume":"106","author":"Kinoshita","year":"2010","journal-title":"Circ Res"},{"key":"10.1124\/jpet.115.226092_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00395-010-0098-z","article-title":"Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2","volume":"105","author":"Klaiber","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.115.226092_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.yjmcc.2009.11.015","article-title":"Cyclic GMP\/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation: novel mechanism of cardiac stress modulation by PDE5 inhibition","volume":"48","author":"Koitabashi","year":"2010","journal-title":"J Mol Cell Cardiol"},{"issue":"Suppl","key":"10.1124\/jpet.115.226092_bib31","doi-asserted-by":"crossref","first-page":"LB650","DOI":"10.1096\/fasebj.28.1_supplement.lb650","article-title":"Administration of sildenafil at reperfusion fails to reduce infarct size: results from the CAESAR Cardioprotection Consortium (Abstract)","volume":"28","author":"Kukreja","year":"2014","journal-title":"FASEB J"},{"key":"10.1124\/jpet.115.226092_bib32","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circ Res"},{"key":"10.1124\/jpet.115.226092_bib33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"10.1124\/jpet.115.226092_bib34","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/01.CIR.0000029923.57048.61","article-title":"Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart","volume":"106","author":"Li","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.226092_bib35","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"L\u00f3pez-Send\u00f3n","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.115.226092_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tips.2014.05.003","article-title":"Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond","volume":"35","author":"Lukowski","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.115.226092_bib37","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1073\/pnas.1001360107","article-title":"Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes","volume":"107","author":"Lukowski","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.226092_bib38","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/ATVBAHA.108.166405","article-title":"Role of smooth muscle cGMP\/cGKI signaling in murine vascular restenosis","volume":"28","author":"Lukowski","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.115.226092_bib39","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/01.HYP.0000241087.12492.47","article-title":"Soluble guanylate cyclase stimulation on cardiovascular remodeling in angiotensin II-induced hypertensive rats","volume":"48","author":"Masuyama","year":"2006","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.226092_bib40","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1124\/jpet.115.226092_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.115.226092_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00395-013-0337-1","article-title":"Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G","volume":"108","author":"Methner","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.115.226092_bib43","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.109.198515","article-title":"Role of Ca2+\/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy","volume":"105","author":"Miller","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/jpet.115.226092_bib44","doi-asserted-by":"crossref","first-page":"e14227","DOI":"10.1371\/journal.pone.0014227","article-title":"Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II","volume":"5","author":"Mokni","year":"2010","journal-title":"PLoS One"},{"key":"10.1124\/jpet.115.226092_bib45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.yjmcc.2008.12.008","article-title":"Pressure-overload magnitude-dependence of the anti-hypertrophic efficacy of PDE5A inhibition","volume":"46","author":"Nagayama","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1124\/jpet.115.226092_bib46","doi-asserted-by":"crossref","first-page":"13244","DOI":"10.1074\/jbc.M109.074104","article-title":"Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition","volume":"285","author":"Nishida","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.115.226092_bib47","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cardiores.2005.10.001","article-title":"The role of natriuretic peptides in cardioprotection","volume":"69","author":"Nishikimi","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.115.226092_bib48","doi-asserted-by":"crossref","first-page":"H1263","DOI":"10.1152\/ajpheart.00324.2002","article-title":"Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits","volume":"283","author":"Ockaili","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.115.226092_bib49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.97.2.931","article-title":"Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling","volume":"97","author":"Paradis","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.226092_bib50","doi-asserted-by":"crossref","first-page":"12925","DOI":"10.1073\/pnas.1414364111","article-title":"Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis","volume":"111","author":"Patrucco","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.115.226092_bib51","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1124\/jpet.115.226092_bib52","doi-asserted-by":"crossref","first-page":"H2018","DOI":"10.1152\/ajpheart.01092.2010","article-title":"Overexpression of type 1 angiotensin II receptors impairs excitation-contraction coupling in the mouse heart","volume":"301","author":"Rivard","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.115.226092_bib53","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.ajpheart.91438.2007","article-title":"Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice","volume":"294","author":"Salloum","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.115.226092_bib54","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1172\/JCI70731","article-title":"PDE5 inhibitor efficacy is estrogen dependent in female heart disease","volume":"124","author":"Sasaki","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.115.226092_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvp002","article-title":"Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling","volume":"82","author":"Sch\u00e4fer","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.115.226092_bib56","doi-asserted-by":"crossref","first-page":"e103402","DOI":"10.1371\/journal.pone.0103402","article-title":"KCNMA1 encoded cardiac BK channels afford protection against ischemia-reperfusion injury","volume":"9","author":"Soltysinska","year":"2014","journal-title":"PLoS One"},{"key":"10.1124\/jpet.115.226092_bib57","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1172\/JCI40295","article-title":"Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload","volume":"120","author":"Takeda","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.115.226092_bib58","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1253\/circj.CJ-12-0664","article-title":"Cyclic GMP-dependent signaling in cardiac myocytes","volume":"76","author":"Takimoto","year":"2012","journal-title":"Circ J"},{"key":"10.1124\/jpet.115.226092_bib59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat Med"},{"key":"10.1124\/jpet.115.226092_bib60","first-page":"408","article-title":"Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice","volume":"119","author":"Takimoto","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.115.226092_bib61","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/CIRCULATIONAHA.108.847731","article-title":"Cell communications in the heart","volume":"122","author":"Tirziu","year":"2010","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.226092_bib62","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1161\/CIRCULATIONAHA.107.732990","article-title":"Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart","volume":"117","author":"Tokudome","year":"2008","journal-title":"Circulation"},{"key":"10.1124\/jpet.115.226092_bib63","doi-asserted-by":"crossref","first-page":"32749","DOI":"10.1074\/jbc.M703173200","article-title":"Cyclic nucleotide phosphodiesterase PDE1C1 in human cardiac myocytes","volume":"282","author":"Vandeput","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.115.226092_bib64","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00395-012-0308-y","article-title":"Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo","volume":"107","author":"Westermann","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.115.226092_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/HYPERTENSIONAHA.111.180968","article-title":"Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension","volume":"59","author":"Xie","year":"2012","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.226092_bib66","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.111.175208","article-title":"Agonist-independent constitutive activity of angiotensin II receptor promotes cardiac remodeling in mice","volume":"59","author":"Yasuda","year":"2012","journal-title":"Hypertension"},{"key":"10.1124\/jpet.115.226092_bib67","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacc.2010.08.612","article-title":"Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5","volume":"56","author":"Zhang","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.226092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:01:39Z","timestamp":1739988099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524190933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0022356524190933"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.226092","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sildenafil Does Not Prevent Heart Hypertrophy and Fibrosis Induced by Cardiomyocyte Angiotensin II Type 1 Receptor Signaling","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.226092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}